Clinical Trial: Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Neonatal Estimation Of Brain Damage Risk And Identification of Neuroprotectants

Brief Summary: NEOBRAIN brings together small and medium sized enterprises (SMEs), industry and academic groups devoted to the diagnosis, management, and neuroprotection in newborns with perinatal brain damage. The focus of NEOBRAIN is to identify strategies prevention of brain damage mainly observed in preterm newborns. (Copy from www.neobrain.eu)

Detailed Summary:
Sponsor: Hannover Medical School

Current Primary Outcome: Brain white matter damage (WMD, defined by MRI ,US, EEG) [ Time Frame: during stay in NICU and until discharge ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Developmental assessment [ Time Frame: at 2 years of age ]

Original Secondary Outcome: Same as current

Information By: Hannover Medical School

Dates:
Date Received: October 12, 2007
Date Started: October 2007
Date Completion:
Last Updated: June 22, 2011
Last Verified: June 2011